Lindbrook Capital, LLC Cyteir Therapeutics, Inc. Transaction History
Lindbrook Capital, LLC
- $1.05 Billion
- Q1 2024
A detailed history of Lindbrook Capital, LLC transactions in Cyteir Therapeutics, Inc. stock. As of the latest transaction made, Lindbrook Capital, LLC holds 2,006 shares of CYT stock, worth $6,038. This represents 0.0% of its overall portfolio holdings.
Number of Shares
2,006
Previous 2,006
-0.0%
Holding current value
$6,038
Previous $6,000
-0.0%
% of portfolio
0.0%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding CYT
# of Institutions
6Shares Held
6.18MCall Options Held
0Put Options Held
0-
Bml Capital Management, LLC Zionsville, IN3.65MShares$11 Million7.36% of portfolio
-
Oup Management Co., LLC2.46MShares$7.4 Million15.71% of portfolio
-
Acadian Asset Management LLC Boston, MA26.3KShares$79,2200.0% of portfolio
-
Boston Family Office LLC Boston, MA24.2KShares$72,8320.01% of portfolio
-
Act Capital Management, LLC Wayne, PA15KShares$45,1500.04% of portfolio
About Cyteir Therapeutics, Inc.
- Ticker CYT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 35,413,400
- Market Cap $107M
- Description
- Cyteir Therapeutics, Inc., a clinical-stage biotechnology company, develops and commercializes the next-generation of precision oncology medicines. Its lead product CYT-0851, a novel, oral, once-daily, small molecule drug candidate that is in Phase I/II clinical trial for monotherapy in solid tumors and hematologic malignancies, as well as for c...